Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Powell

Showing results (71-80 of 138) with videos related to

Pageof 14
Sort By:
Journal of Translational Medicine|August 11, 2011
Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytesQunrui Ye, Maria Loisiou, Bruce L Levine, et al.
Journal for Immunotherapy of Cancer|July 13, 2021
Dichotomous impact of affinity on the function of T cell engaging bispecific antibodiesMathilde Poussin, Arlene Sereno, Xiufeng Wu, et al.
Cancer Research|February 9, 2012
A universal strategy for adoptive immunotherapy of cancer through use of a novel T-cell antigen receptorKatarzyna Urbanska, Evripidis Lanitis, Mathilde Poussin, et al.
General and Comparative Endocrinology|May 27, 2022
Structural variation between neuropeptide isoforms affects function in the lobster cardiac systemAudrey J Muscato, Daniel J Powell, Warsameh Bulhan, et al.
Critical Reviews in Immunology|November 26, 2013
Therapeutic dendritic cell-based cancer vaccines: the state of the artMarius M Strioga, Thomas Felzmann, Daniel J Powell, et al.
Oncotarget|July 14, 2016
Multiparameter comparative analysis reveals differential impacts of various cytokines on CART cell phenotype and function ex vivo and in vivoXiao-Jun Xu, De-Gang Song, Mathilde Poussin, et al.
Journal of Translational Medicine|May 26, 2011
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapyIoannis Alagkiozidis, Andrea Facciabene, Marinos Tsiatas, et al.
Cancer Research|June 1, 2013
Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responsesDenarda Dangaj, Evripidis Lanitis, Aizhi Zhao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytesLaura A Johnson, Bianca Heemskerk, Daniel J Powell, et al.
Gynecologic Oncology|September 1, 2023
The spectrum of MAPK-ERK pathway genomic alterations in gynecologic malignancies: Opportunities for novel therapeutic approachesDimitrios Nasioudis, Marta Llaurado Fernandez, Nelson Wong, et al.
Pageof 14

Showing results (71-80 of 138) with videos related to

Sort By:
Pageof 14
Journal of Translational Medicine|August 11, 2011
Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytesQunrui Ye, Maria Loisiou, Bruce L Levine, et al.
Journal for Immunotherapy of Cancer|July 13, 2021
Dichotomous impact of affinity on the function of T cell engaging bispecific antibodiesMathilde Poussin, Arlene Sereno, Xiufeng Wu, et al.
Cancer Research|February 9, 2012
A universal strategy for adoptive immunotherapy of cancer through use of a novel T-cell antigen receptorKatarzyna Urbanska, Evripidis Lanitis, Mathilde Poussin, et al.
General and Comparative Endocrinology|May 27, 2022
Structural variation between neuropeptide isoforms affects function in the lobster cardiac systemAudrey J Muscato, Daniel J Powell, Warsameh Bulhan, et al.
Critical Reviews in Immunology|November 26, 2013
Therapeutic dendritic cell-based cancer vaccines: the state of the artMarius M Strioga, Thomas Felzmann, Daniel J Powell, et al.
Oncotarget|July 14, 2016
Multiparameter comparative analysis reveals differential impacts of various cytokines on CART cell phenotype and function ex vivo and in vivoXiao-Jun Xu, De-Gang Song, Mathilde Poussin, et al.
Journal of Translational Medicine|May 26, 2011
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapyIoannis Alagkiozidis, Andrea Facciabene, Marinos Tsiatas, et al.
Cancer Research|June 1, 2013
Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responsesDenarda Dangaj, Evripidis Lanitis, Aizhi Zhao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytesLaura A Johnson, Bianca Heemskerk, Daniel J Powell, et al.
Gynecologic Oncology|September 1, 2023
The spectrum of MAPK-ERK pathway genomic alterations in gynecologic malignancies: Opportunities for novel therapeutic approachesDimitrios Nasioudis, Marta Llaurado Fernandez, Nelson Wong, et al.
Pageof 14